NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
February 21, 2020
Durham-based Mycovia Pharmaceuticals has extended its Phase 3 clinical trials of its lead drug candidate for treating recurrent yeast infections in women.
February 20, 2020
The Raleigh-based company, launched in 2016, uses patented thermal food processing technology to produce shelf-stable products that don’t need refrigeration until their packages are opened.
February 19, 2020
GreenLight Biosciences, headquartered in Boston, expects to double the size of its Research Triangle Park plant and data science operation over the next two years.
February 19, 2020
Raleigh-based biotechnology company Arrevus has received an Orphan Drug Designation from the FDA for its ARV-1801, an oral antibiotic to treat cystic fibrosis lung infections, .
February 18, 2020
Audentes Therapeutics, a San Francisco gene therapy company, today announced plans for a $109.4 million, 209-employee gene therapy production facility in Sanford, a short distance from a $600 million Pfizer gene therapy campus under construction.
February 16, 2020
Bob Jordan, a visionary leader who helped build the foundation for North Carolina’s global life science leadership, died today at the age of 87.
February 13, 2020
The newly published 2020 edition of the “Window on the Workplace” study analysis says North Carolina's long-term commitment to biopharma workforce readiness will need to adjust and grow to meet coming demand.
February 13, 2020
Early registration for next month’s Venture Connect Summit at the Raleigh Convention Center closes on Feb. 14, offering discounted admission to the entrepreneurial showcase and networking event.
February 12, 2020
Duke scientists say an instrumentation grant from NCBiotech enables them to use cutting-edge digital imaging and AI technologies to advance cancer research, diagnostics and to support a vast new initiative called AI Health.
February 12, 2020
T3D Therapeutics has enlisted an all-star team of Alzheimer’s disease experts to guide the science behind its potential drugs for treating the affliction.
February 11, 2020
T3D Therapeutics is launching a Phase 2 clinical trial with its unique product candidate, T3D-959, to treat mild to moderate forms of Alzheimer’s disease.
February 10, 2020
Learn how large ag tech companies decide what to pursue when they’re looking 15 years into the future at the next Ag Tech Professional Forum Feb. 19 at the North Carolina Biotechnology Center.
February 6, 2020
Bioscience ventures in southeastern NC can compete for up to $20,000 in awards this spring through a new program created by NCBiotech and supported by UNCW and the New Hanover Regional Medical Center.
February 6, 2020
A successful Phase 3 trial of Polarean Imaging’s drug-device combination for lung imaging has the Research Triangle Park company poised to seek next-step advice from FDA regulators.
February 5, 2020
The North Carolina Biotechnology Center awarded 23 grants and loans totaling $2.1 million during the past fiscal quarter to bioscience companies, universities and non-profit organizations.